There’s been a lot of back and forth action in this market and it seems as if traders are just reacting to whatever the talking heads and headlines say.

The POTUS has been symptom-free for a day, and now the attention has been switched back to the stimulus.

To be honest with you, that catalyst is too much of a coin flip to me…

I believe there are better opportunities out there, ones that don’t rely on politics or market-wide catalysts.

You see, this month there are a slew of upcoming catalysts in my favorite area of the market — biotechs…

And it can possibly the next hot sector filled with mind-boggling risk-reward opportunities.

I want to show you which specific areas in the biotech industry I believe will take off this month, and a little bit about a sub $10 stock I have my eyes on.


Why Biotechs Are Set To Pop Off


There’s just so much action in biotechs.

Think about it, we’ve got an upcoming flu season, a heap of biotech conferences, and most importantly…

The race to find a cure or treatment for COVID-19.

There’s been an uptick in coronavirus cases in specific areas, and that means some states may have to head back into quarantine.

That means there will be more eyes on the industry, and the moves can be outsized.

While I do focus on biotechs in general, there are specific areas that I believe will offer the best opportunities:

  • Diagnostics
  • Therapeutics
  • Vaccinations

Diagnostics will be in focus because they’ll play a key role in testing the population for coronavirus.

Therapeutics may be used to treat COVID-19… and vaccinations can help to prevent it.

I mean, there are biotechs that have moved 500% this year so far, and I believe stocks in those areas can offer the best money-making opportunities.

As I dug deep and searched for these opportunities, I came across a relatively unknown company.

It’s trading in the $5-$10 range…so I believe it’s something a lot of traders with small accounts can get involved in.

This is a stock I believe you will be hearing a lot about.

You see, the company has developed a product for COVID-19 that is a flat out game changer.

The Department of Defense has struck a deal with them, and I wouldn’t be surprised if there are larger deals on the way.

To be honest with you, it’s very rare you see a stock like this, trade under $10 per share

I would also consider this stock a low float. That means if there the demand for it picks up, it can have outsized moves. Additionally, more than 20% shares of the stock are sold short. If there’s a catalyst, I believe the shorts will head to the exit and further drive the demand for shares.

With upcoming catalysts on the table, I want to get in before the herd hears about it… and lock in hefty profits.

The market waits for no one…

That’s why I’m set to release this catalyst trade idea very soon.

I’m up more than $3.8M on the year and my catalyst runup played a large role.*

If you want to find out what it’s all about and how to get in on the action, then you’ll have to join Trade With Kyle.

This is something you don’t want to miss out on.


*Results presented are not typical and may vary from person to person. Please see our full disclaimer here: ragingbull.com/disclaimer

Kyle Dennis

Straight outta college Kyle Dennis taught himself to trade, and then made over $7 million in trading profits by the time he was 28 years old. Kyle reveals how to find, track, and profit from lucrative trades for exceptional profits. Thousands of traders follow him every day to learn how to target these high probability trades.

Learn More

Leave your comment